Skip to main content

Innovative cancer therapy through Myc inhibition: taking OMO-103 to market

Project description

A novel cancer therapy penetrates cancer cell nuclei to reach their Achilles heel

Field of science

  • /social sciences/economics and business
  • /medical and health sciences/clinical medicine/cancer
  • /humanities/languages and literature/linguistics/phonetics

Call for proposal

H2020-SMEInst-2018-2020-2
See other projects for this call

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

PEPTOMYC SL
Address
Center Cellex, Calle Natzaret 115-117
08035 Barcelona
Spain
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 219 553,52